Reactive cutaneous capillary endothelial proliferation predicted the efficacy of camrelizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma

BACKGROUND: Reactive cutaneous capillary endothelial proliferation (RCCEP), a special adverse event (AE) only observed in patients treated with camrelizumab, was reported to be correlated with the efficacy of camrelizumab in patients with advanced hepatocellular carcinoma. This study to analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Qi, Liu, Yang, Ju, Houyu, Song, Hao, Xiao, Yuanzhe, Liu, Xiulan, Ren, Guoxin, Wei, Dongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635619/
https://www.ncbi.nlm.nih.gov/pubmed/37330963
http://dx.doi.org/10.4317/medoral.25919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635619/
https://www.ncbi.nlm.nih.gov/pubmed/37330963
http://dx.doi.org/10.4317/medoral.25919

Ejemplares similares